A detailed history of Vr Adviser, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 454,450 shares of ARVN stock, worth $8.24 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
454,450
Previous 627,788 27.61%
Holding current value
$8.24 Million
Previous $16.7 Million 33.02%
% of portfolio
1.16%
Previous 1.83%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.66 - $32.73 $4.1 Million - $5.67 Million
-173,338 Reduced 27.61%
454,450 $11.2 Million
Q4 2023

Feb 14, 2024

BUY
$14.19 - $42.33 $8.91 Million - $26.6 Million
627,788 New
627,788 $25.8 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $965M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.